Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
Chemistry & Biology2000Vol. 7(10), pp. 793–803
Citations Over TimeTop 10% of 2000 papers
Matthew P. Coghlan, Ainsley A. Culbert, Darren A.E. Cross, Stacey L. Corcoran, John Yates, Neil Pearce, Oliver Rausch, Gregory Murphy, Paul S. Carter, Lynne Roxbee Cox, David Mills, Murray J. B. Brown, David Haigh, Robert W. Ward, David G. Smith, Kenneth Murray, Alastair D. Reith, Julie C. Holder
Related Papers
- → Glycogen synthase kinase 3: more than a namesake(2009)470 cited
- → In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3(2003)215 cited
- → GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activity(2001)85 cited
- → [The role of glycogen synthase kinase-3 beta in the pathogenesis of liver ischemia reperfusion injury].(2011)
- → GSK3B wt Allele(2020)